20,000+ Scientists & Academics
4,000+ Scientific disciplines
20,000+ Projects posted
Trusted by 3,200+ businesses
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
USD 50 /hr
Hire Dr. Christophe Pichavant
United States
USD 50 /hr
Profile Summary
Subject Matter Expertise
Work Experience


Stanford University

November 2018 - Present



October 2017 - October 2018

Postdoc & research staff

Stanford University

September 2014 - October 2017

Postdoc & instructor

Emory University

February 2011 - August 2014



Laval University

August 2005 - December 2010

  • Certification details not provided.
Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P., Ma, J., Pichavant, C., du Bois, H., Bhakta, M., Calos, M.P.(2017). DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B . Molecular Therapy - Methods and Clinical Development. 7. p. 123-131.
Simionescu-Bankston, A., Pichavant, C., Canner, J.P., Apponi, L.H., Wang, Y., Steeds, C., Olthoff, J.T., Belanto, J.J., Ervasti, J.M., Pavlath, G.K.(2015). Creatine kinase B is necessary to limit myoblast fusion during myogenesis . American Journal of Physiology - Cell Physiology. 308. (11). p. C919-C931.
Pichavant, C., Pavlath, G.K.(2014). Incidence and severity of myofiber branching with regeneration and aging . Skeletal Muscle. 4. (1).
Pichavant, C., Aartsma-Rus, A., Clemens, P.R., Davies, K.E., Dickson, G., Takeda, S., Wilton, S.D., Wolff, J.A., Wooddell, C.I., Xiao, X., et al.(2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD . Molecular Therapy. 19. (5). p. 830-840.
Pichavant, C., Chapdelaine, P., Cerri, D.G., Dominique, J.-C., Quenneville, S.P., Skuk, D., Kornegay, J.N., Bizario, J.C., Xiao, X., Tremblay, J.P.(2010). Expression of dog microdystrophin in mouse and dog muscles by gene therapy . Molecular Therapy. 18. (5). p. 1002-1009.
Pichavant, C., Chapdelaine, P., Cerri, D.G., Bizario, J.C.S., Tremblay, J.P.(2010). Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles . Human Gene Therapy. 21. (11). p. 1591-1601.
Chapdelaine, P., Pichavant, C., Rousseau, J., Pâques, F., Tremblay, J.P.(2010). Meganucleases can restore the reading frame of a mutated dystrophin . Gene Therapy. 17. (7). p. 846-858.
Stephan, L., Pichavant, C., Bouchentouf, M., Mills, P., Camirand, G., Tagmouti, S., Rothstein, D., Tremblay, J.P.(2006). Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use . Cell Transplantation. 15. (8-9). p. 835-846.
Pichavant, C., Tremblay, J.P.(2012). Generation of lentiviral vectors for use in skeletal muscle research . Methods in Molecular Biology. 798. p. 285-295.